Evidence map›Paper›PMID 30115631›Full record

ArticleGenes & development2018

TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.

Takashi Yamazaki, Lizhi Liu, Denis Lazarev, Amr Al-Zain, Vitalay Fomin, Percy Luk Yeung, Stuart M Chambers, Chi-Wei Lu, Lorenz Studer, James L Manley

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Genes & development, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. HNRNPH1-mediated splicing events regulatebioRxiv : the preprint server for biology · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Function of E2A in B-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  19. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Takashi YamazakiDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Lizhi LiuDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Denis LazarevDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Amr Al-ZainDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Vitalay FominDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Percy Luk YeungDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Child Health Institute of New Jersey, New Brunswick, New Jersey 08901, USA.
Stuart M ChambersThe Center for Stem Cell Biology, Sloan Kettering Institute, New York, New York 10065, USA.
Chi-Wei LuDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Child Health Institute of New Jersey, New Brunswick, New Jersey 08901, USA.
Lorenz StuderThe Center for Stem Cell Biology, Sloan Kettering Institute, New York, New York 10065, USA.
James L ManleyDepartment of Biological Sciences, Columbia University, New York, New York 10027, USA.
Columbia University · USKettering University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Regulation of RNA processing: Mechanisms and ConsequencesR35GM118136 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI James L. Manley · 2016 to 2026
$8.9M
Alternative Cleavage and Polyadenylation in Trophoblast DifferentiationR21HD081682 · NICHD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LU, CHI-WEI, TIAN, BIN · 2015 to 2016
$435k
NCI NIH HHS P30 CA008748NICHD NIH HHS R21 HD081682NIGMS NIH HHS R35 GM118136
6 · The paper itself

Abstract

Alternative splicing (AS) plays important roles in embryonic stem cell (ESC) differentiation. In this study, we first identified transcripts that display specific AS patterns in pluripotent human ESCs (hESCs) relative to differentiated cells. One of these encodes T-cell factor 3 (TCF3), a transcription factor that plays important roles in ESC differentiation. AS creates two TCF3 isoforms, E12 and E47, and we identified two related splicing factors, heterogeneous nuclear ribonucleoproteins (hnRNPs) H1 and F (hnRNP H/F), that regulate TCF3 splicing. We found that hnRNP H/F levels are high in hESCs, leading to high E12 expression, but decrease during differentiation, switching splicing to produce elevated E47 levels. Importantly, hnRNP H/F knockdown not only recapitulated the switch in TCF3 AS but also destabilized hESC colonies and induced differentiation. Providing an explanation for this, we show that expression of known TCF3 target E-cadherin, critical for maintaining ESC pluripotency, is repressed by E47 but not by E12.

Indexed as

Alternative SplicingAntigens, CDBasic Helix-Loop-Helix ProteinsCadherinsCell DifferentiationCell LineEmbryonic Stem CellsExonsGene Expression RegulationHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansRegulatory Sequences, Ribonucleic AcidRNA, MessengerRNA PrecursorsAntigens, CDBasic Helix-Loop-Helix ProteinsCadherinsCDH1 protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HRegulatory Sequences, Ribonucleic AcidRNA, MessengerRNA PrecursorsTCF3 protein, humanalternative splicingE2Aheterogeneous nuclear ribonucleoproteinhuman embryonic stem cellT-cell factor 3

Identifiers

PMID30115631
PMCPMC6120717
OpenAlexW2887565760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.